Brown-Forman stock has fallen sharply over the past few years, yet the latest Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares may still be trading at a discount to what the company’s cash flows imply.

• Brown-Forman shareholders have seen the stock decline about 60.4% over the past 3 years, which puts recent pricing under closer scrutiny for signs of a possible reset or a value trap.
• The planned retirement of long-serving CEO Lawson Whiting and a difficult operating backdrop can weigh on confidence, while any successor who can steady execution and capital allocation may support how investors value the business.
• On Simply Wall St’s broader checks, Brown-Forman screens as undervalued in 5 of 6 areas, indicating the stock looks inexpensive across several commonly used valuation measures.

The issue now is whether Brown-Forman’s recent share price weakness and high valuation score genuinely point to an undervalued opportunity or simply reflect the risks that have built up around the business.

Does Brown-Forman Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what Brown-Forman’s future cash generation could be worth today. On the latest twelve-month numbers, Brown-Forman produced free cash flow of about $836.8 million, and the model uses a two stage free cash flow to equity approach with a broadly recovering cash flow profile over time.

Based on these projections, the DCF model points to an intrinsic value of about $38.67 per share. This implies the stock trades at roughly a 33.5% discount to this estimate. The retirement of long-serving CEO Lawson Whiting and the ongoing leadership search help explain why the share price may sit below the value implied by the cash flow outlook, despite the company reiterating its medium term targets.

Overall, the Discounted Cash Flow (DCF) work suggests Brown-Forman stock currently screens as undervalued relative to its projected cash flows.

Our Discounted Cash Flow (DCF) analysis suggests Brown-Forman is undervalued by 33.5%. Track this in your watchlist or portfolio, or discover 38 more high quality undervalued stocks.

Where Does Brown-Forman Sit on Earnings?

P/E is usually a useful way to look at Brown-Forman because earnings are a central focus for mature consumer brands. Brown-Forman trades on a P/E of about 16.5x, which sits just below the Beverage industry average of roughly 17.4x and far below a peer group average closer to 40.6x.

The fair P/E ratio for Brown-Forman, based on its profile and risk factors, is estimated at about 17.4x, only slightly above where the stock currently trades. That small gap suggests the market price is broadly in line with what the earnings, sector, and business characteristics might justify, even with leadership uncertainty and a mixed recent operating backdrop in view.

On balance, Brown-Forman appears roughly fairly valued on its P/E multiple.

The Brown-Forman Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Brown-Forman valuation puzzle leaves off by spelling out which assumptions about Brown-Forman's future growth, margins, and earnings would need to hold for the stock to be worth meaningfully more or less than today’s price, and they sit on the company’s Community page. Rather than relying on a single multiple or model output, each narrative lays out the drivers behind its view of fair value so you can later compare those assumptions with the results the company actually reports.

The community is split between two very different scenarios for Brown-Forman, with one side focusing on premium growth options and the other on long-term demand and regulation risks.

Bull case: 8% undervalued

"Brown-Forman is realizing strong organic net sales growth in emerging international markets (25%+ in some regions like Brazil and Mexico), driven by strategic focus on premiumization and distribution of flagship and super-premium brands. This positions the company to benefit as the global middle class expands, supporting future revenue and geographic diversification, which may help offset U.S. market uncertainty…"

Bear case: 28% overvalued

"Ongoing shifts in consumer preferences due to rising health consciousness and increased moderation, particularly among younger demographics, are expected to drive sustained declines in alcohol consumption. This directly pressures Brown-Forman's long-term revenue and may limit category expansion potential globally…"

Do you think there's more to the story for Brown-Forman? Head over to our Community to see what others are saying!

The Bottom Line

Brown-Forman screens as undervalued on a Discounted Cash Flow (DCF) view, while its P/E multiple sits close to what the sector and business profile might justify. That mix points to a stock where the market is cautious on growth, execution and leadership transition, even though the intrinsic value estimate suggests more support from cash flows. With broader valuation checks looking relatively strong, the key question is whether Brown-Forman can deliver on its cash flow and earnings ambitions without impairing returns, or whether current discounts are simply compensation for ongoing demand and regulatory risks in its core category.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.